According to FutureWise analysis the market for Radiation Toxicity Treatment in 2023 is US$ 3.99 billion, and is expected to reach US$ 6.36 billion by 2031 at a CAGR of 6.00%.
The rising installations of radiation therapy machines for treating different cancer types has increased radiation toxicity in patients. Furthermore, favourable reimbursements and government policies for cancer treatments has made radiation therapy ore accessible, thereby boosting the radiation toxicity treatment market growth. Moreover, the increased acceptance of factors that are colony stimulated shall boost the proliferation of the market. Additionally, parameters like positive product reviews, financials have bolstered the augmentation of the market. According to the American cancer Society, over 17,35,000 cancer cases were registered in 2018. Such a high prevalence of cancer shall increase the number of patients getting diagnosed with radiation toxicity, thereby propelling the market growth. Radiation toxicity is primarily caused by exposure to radiations in nuclear power plants either intentionally or accidently. With many countries investing in nuclear energy, there has been a rise in the number of nuclear plants, increasing the chances of people getting toxified by radiations, resulting in the augmentation of the market.